ClinicalTrials.Veeva

Menu

Detection of Viral Particels in Urticaria Patients

H

HaEmek Medical Center, Israel

Status

Completed

Conditions

Urticaria Chronic

Study type

Observational

Funder types

Other

Identifiers

NCT03151902
HaEmekMC1

Details and patient eligibility

About

Blood samples from urticaria patients will be analyzed for viral particles

Full description

After digestion with DNase to eliminate human DNA, RNA will be reversed-transcribed and amplified with random primer/ Amplification products will be pooled and sequenced/ After substruction of sequences of vertebrates and highly repetitive sequences, contiguous sequences will be assembled and compared with motifs represented in databases of viruses. which will enable identification of putative protein sequences consistent with viruses

Enrollment

10 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with chronic spontaneous urticaria

Exclusion criteria

  • none

Trial contacts and locations

1

Loading...

Central trial contact

Menachem Rottem, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems